This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

134 Resources
134 Resources
134 Resources
    Date
  1. Training and competency assessment tool for users of the STANDARD G6PD Test
    Published: June 2022
    Type: Resource Page
  2. Examples of patient G6PD counseling cards
    Published: June 2022
    Type: Resource Page
  3. A research study of close contacts of individuals with COVID-19 in Brazil finds that POC rapid antigen tests for SARS-CoV-2 are highly versatile and useful tools for combatting the COVID-19 pandemic. The study demonstrates the near immediate time-to-result of POC rapid antigen tests significantly offsets reduced sensitivity by enabling early identification of positive cases and decreasing onward viral transmission. In settings where RT-PCR is unavailable due to financial or infrastructure limitations, or where time-to-results is >4 days, close to 90% of individuals with Ct<34 could benefit from an earlier result via a POC test. Even in settings where PCR results are available within 24 hours, cumulative sensitivity of a POC test is >70%.
    Published: February 2022
    Type: Resource Page
  4. Findings from a research study assessing knowledge of G6PD deficiency, practice of treating patients with G6PD deficiency, and perceptions about point-of-care G6PD deficiency tests in India, Indonesia and Vietnam.
    Published: February 2022
    Type: Resource Page
  5. Private companies have limited incentive to develop products that address poverty-related diseases such as malaria, HIV, and tuberculosis because the chances of technical failure during development are high and the potential for profit may be minimal. But over the past two decades, a critical tool has emerged to help address this gap: the product development partnership(PDP), which brings together public, private, academic, and philanthropic expertise and funding to develop and deliver global health products that would otherwise have little or no chance of coming to market. Many of these PDPs take a portfolio-based approach, spreading investments among multiple companies to increase the probability that at least one viable product will emerge to meet the need. This paper examines one successful PDP effort, PATH’s G6PD Diagnostic Initiative, to highlight key factors that can lead to challenges and contribute to success. Although each PDP is unique, and PDPs can vary greatly in scale, scope, and the number and configuration of partners, many of the lessons from this initiative are broadly applicable to other global health efforts and may be helpful to funders, product developers, policymakers, and researchers as they consider engaging in PDPs.
    Published: January 2022
    Type: Resource Page
Load more